Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,461 | -51,980 | -64,806 | -22,414 | -13,160 |
| Depreciation Amortization | 255 | 142 | 80 | 57 | 12 |
| Accounts payable and accrued liabilities | -654 | 1,650 | 1,076 | 187 | 591 |
| Other Working Capital | 3,940 | -788 | 997 | 914 | 1,813 |
| Other Operating Activity | 5,830 | 5,418 | 31,183 | 3,455 | 5,259 |
| Operating Cash Flow | $-51,091 | $-45,559 | $-31,470 | $-17,802 | $-5,486 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,797 | -5,012 | N/A | N/A | N/A |
| PPE Investments | -57 | -34 | -39 | -30 | -32 |
| Purchase Sale Intangibles | -187 | -318 | -9 | -159 | -24 |
| Other Investing Activity | -187 | -318 | -9 | -159 | -24 |
| Investing Cash Flow | $-30,041 | $-5,364 | $-47 | $-189 | $-56 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64,253 | 286 | 69,777 | N/A | N/A |
| Other Financing Activity | 22,287 | 0 | -3,074 | -14 | 70,639 |
| Financing Cash Flow | $86,539 | $286 | $66,703 | $-14 | $70,639 |
| Beginning Cash Position | 36,490 | 87,126 | 51,940 | 69,944 | 4,847 |
| End Cash Position | 41,897 | 36,490 | 87,126 | 51,940 | 69,944 |
| Net Cash Flow | $5,408 | $-50,636 | $35,186 | $-18,005 | $65,097 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,091 | -45,559 | -31,470 | -17,802 | -5,486 |
| Capital Expenditure | -57 | -34 | -39 | -30 | -32 |
| Free Cash Flow | -51,148 | -45,592 | -31,509 | -17,832 | -5,518 |